Dopamine ameliorates hyperglycemic memory-induced microvascular dysfunction in diabetic retinopathy
- PMID: 36331561
- DOI: 10.1096/fj.202200865R
Dopamine ameliorates hyperglycemic memory-induced microvascular dysfunction in diabetic retinopathy
Abstract
Dopamine is a neurotransmitter that mediates visual function in the retina and diabetic retinopathy (DR) is the most common microvascular complication of diabetes and the leading cause of blindness; however, the role of dopamine in retinal vascular dysfunction in DR remains unclear. Here, we report a mechanism of hyperglycemic memory (HGM)-induced retinal microvascular dysfunction and the protective effect of dopamine against the HGM-induced retinal microvascular leakage and abnormalities. We found that HGM induced persistent oxidative stress, mitochondrial membrane potential collapse and fission, and adherens junction disassembly and subsequent vascular leakage after blood glucose normalization in the mouse retinas. These persistent hyperglycemic stresses were inhibited by dopamine treatment in human retinal endothelial cells and by intravitreal injection of levodopa in the retinas of HGM mice. Moreover, levodopa supplementation ameliorated HGM-induced pericyte degeneration, acellular capillary and pericyte ghost generation, and endothelial apoptosis in the mouse retinas. Our findings suggest that dopamine alleviates HGM-induced retinal microvascular leakage and abnormalities by inhibiting persistent oxidative stress and mitochondrial dysfunction.
Keywords: diabetic retinopathy; dopamine; hyperglycemic memory; microvascular dysfunction; mitochondrial dysfunction.
© 2022 Federation of American Societies for Experimental Biology.
References
REFERENCES
-
- Popova E. Role of dopamine in distal retina. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2014;200:333-358.
-
- Mohana Devi S, Mahalaxmi I, Aswathy NP, Dhivya V, Balachandar V. Does retina play a role in Parkinson's disease? Acta Neurol Belg. 2020;120:257-265.
-
- Aung MH, Park HN, Han MK, et al. Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci. 2014;34:726-736.
-
- Chesler K, Motz C, Vo H, et al. Initiation of L-DOPA treatment after detection of diabetes-induced retinal dysfunction reverses retinopathy and provides neuroprotection in rats. Transl Vis Sci Technol. 2021;10:8.
-
- Kim MK, Aung MH, Mees L, et al. Dopamine deficiency mediates early rod-driven inner retinal dysfunction in diabetic mice. Invest Ophthalmol Vis Sci. 2018;59:572-581.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical